Active Stocks
Mon Apr 28 2025 15:57:17
  1. Reliance Industries share price
  2. 1,368.50 5.27%
  1. State Bank Of India share price
  2. 817.60 2.36%
  1. Tata Steel share price
  2. 142.05 2.42%
  1. Tata Motors share price
  2. 668.35 2.06%
  1. Itc share price
  2. 428.80 0.15%
Business News/Market/Market Stats/    Suven Pharmaceuticals

SUVEN PHARMACEUTICALS SUMMARY

Suven Pharmaceuticals is trading 0.94% upper at Rs 1154.00 as compared to its last closing price. Suven Pharmaceuticals has been trading in the price range of 1163.25 & 1132.00. Suven Pharmaceuticals has given 0.39% in this year & -2.13% in the last 5 days.

 

Suven Pharmaceuticals has TTM P/E ratio 103.75 as compared to the sector P/E of 26.62. There are 6 analysts who have initiated coverage on Suven Pharmaceuticals. There are 3 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

 

The company posted a net profit of 82.88 Crores in its last quarter.

 

Listed peers of Suven Pharmaceuticals include Laurus Labs (0.17%), Ajanta Pharma (3.91%), Suven Pharmaceuticals (0.94%) etc.

 

Suven Pharmaceuticals has a 50.1% promoter holding & 49.9% public holding.

FAQs about Suven Pharmaceuticals

Suven Pharmaceuticals is trading at 1154.00 as on 28 Apr, 2025 3:29:06 PM. This is 0.94% upper as compared to its previous closing price of 1143.25
The market capitalization of Suven Pharmaceuticals is 29495.48 Cr as on 28 Apr, 2025 3:29:06 PM.
The average broker rating on Suven Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
  • 0.00 analysts have given a strong sell rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a hold rating
  • 3 analysts have given a buy rating
  • 3 analysts have given a strong buy rating
The 52 wk high for Suven Pharmaceuticals is 1359.00 whereas the 52 wk low is 597.00
Suven Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 103.75
  • Sector P/E: 26.62
  • Dividend Yield: 0%
  • D/E ratio: -
Suven Pharmaceuticals reported a net profit of 300.28 Cr in 2024.
Recommended For You